Diversified Trust’s GenMark Diagnostics, Inc GNMK Stock Holding History

Diversified Trust’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,941	Closed	-$204K	–	878
2020 Q4	$204K	Buy	+13,941	New	+$185K	0.01%	668

Other funds holding GNMK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diversified Trust's GNMK Position: Q1 2021 in Review

Diversified Trust sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 13,941 shares — an estimated $204K sold.

Diversified Trust first reported a position in GNMK in Q4 2020 and held it in 1 quarter. The position peaked at $204K in Q4 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

Diversified Trust reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
Diversified Trust sold 13,941 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $204K.
Diversified Trust first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 1 quarter.
Diversified Trust's GenMark Diagnostics, Inc position peaked at $204K in Q4 2020.
164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Diversified Trust's 13F filing for Q1 2021, filed 10 May 2021.